ABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINES— 510(k) K881817

Substantially Equivalent

Roche Diagnostic Systems, Inc.

FDA 510(k) clearance K881817 for ABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINES, Substantially Equivalent on 1988-07-29. Applicant: Roche Diagnostic Systems, Inc..

Clearance details

Applicant
Roche Diagnostic Systems, Inc.
Product code
Code DJP
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Montclair, NJ, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.